These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 21080891)

  • 1. Centralised faecal blood testing for both screening and pathology requests.
    Edwards JB
    Pathology; 2010 Dec; 42(7):700-4. PubMed ID: 21080891
    [No Abstract]   [Full Text] [Related]  

  • 2. Limitations of the faecal occult blood test in screening for colorectal cancer.
    Delcò F; Sonnenberg A
    Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):119-26. PubMed ID: 10363196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition--Executive summary.
    von Karsa L; Patnick J; Segnan N
    Endoscopy; 2012 Sep; 44 Suppl 3():SE1-8. PubMed ID: 23012113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colonoscopy-controlled intra-individual comparisons to screen relevant neoplasia: faecal immunochemical test vs. guaiac-based faecal occult blood test.
    Oort FA; Terhaar Sive Droste JS; Van Der Hulst RW; Van Heukelem HA; Loffeld RJ; Wesdorp IC; Van Wanrooij RL; De Baaij L; Mutsaers ER; van der Reijt S; Coupe VM; Berkhof J; Bouman AA; Meijer GA; Mulder CJ
    Aliment Pharmacol Ther; 2010 Feb; 31(3):432-9. PubMed ID: 19878150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition--Faecal occult blood testing.
    Halloran SP; Launoy G; Zappa M;
    Endoscopy; 2012 Sep; 44 Suppl 3():SE65-87. PubMed ID: 23012123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Arguments against implementing a population-based screening programme for colorectal cancer].
    Bonneux L
    Ned Tijdschr Geneeskd; 2008 Aug; 152(32):1777. PubMed ID: 18754310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Faecal occult blood test-based screening programme with high compliance for colonoscopy has a strong clinical impact on colorectal cancer.
    Parente F; Marino B; DeVecchi N; Moretti R; ; Ucci G; Tricomi P; Armellino A; Redaelli L; Bargiggia S; Cristofori E; Masala E; Tortorella F; Gattinoni A; Odinolfi F; Pirola ME
    Br J Surg; 2009 May; 96(5):533-40. PubMed ID: 19358181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition--Evaluation and interpretation of screening outcomes.
    Moss S; Ancelle-Park R; Brenner H;
    Endoscopy; 2012 Sep; 44 Suppl 3():SE49-64. PubMed ID: 23012122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Faecal occult blood test-based screening programme with high compliance for colonoscopy has a strong clinical impact on colorectal cancer (Br J Surg 2009; 96: 533-540).
    Nash GF
    Br J Surg; 2009 Aug; 96(8):956-7; author reply 957. PubMed ID: 19591144
    [No Abstract]   [Full Text] [Related]  

  • 10. Screening for colorectal cancer: flexible sigmoidoscopy and faecal occult blood immunochemical testing. Which test is superior?
    Castiglione G
    Gut; 2010 Jan; 59(1):9-10. PubMed ID: 20007956
    [No Abstract]   [Full Text] [Related]  

  • 11. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition--Introduction.
    Lansdorp-Vogelaar I; von Karsa L;
    Endoscopy; 2012 Sep; 44 Suppl 3():SE15-30. PubMed ID: 23012118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal adherence to fecal occult blood testing impacts colorectal cancer screening quality.
    Gellad ZF; Stechuchak KM; Fisher DA; Olsen MK; McDuffie JR; Ostbye T; Yancy WS
    Am J Gastroenterol; 2011 Jun; 106(6):1125-34. PubMed ID: 21304501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Colorectal cancer screening: immunological test for faecal occult blood preferred].
    Jansen JB; van Rossum LG; Laheij RJ
    Ned Tijdschr Geneeskd; 2009; 153():A474. PubMed ID: 19785842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for colorectal cancer: the light at the end of the tunnel.
    Caprilli R; Taddei G
    Ital J Gastroenterol Hepatol; 1997 Apr; 29(2):109-13. PubMed ID: 9646188
    [No Abstract]   [Full Text] [Related]  

  • 15. Early detection of colorectal cancer with faecal occult blood test screening.
    Paimela H; Malila N; Palva T; Hakulinen T; Vertio H; Järvinen H
    Br J Surg; 2010 Oct; 97(10):1567-71. PubMed ID: 20603855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of deaths occurring within the Nottingham trial of faecal occult blood screening for colorectal cancer.
    Whynes DK; Mangham CM; Balfour TW; Scholefield JH
    Gut; 2010 Aug; 59(8):1088-93. PubMed ID: 20639252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A retrospective study of immunochemical fecal occult blood testing for colorectal cancer detection.
    Oono Y; Iriguchi Y; Doi Y; Tomino Y; Kishi D; Oda J; Takayanagi S; Mizutani M; Fujisaki T; Yamamura A; Hosoi T; Taguchi H; Kosaka M; Delgado P
    Clin Chim Acta; 2010 Jun; 411(11-12):802-5. PubMed ID: 20184867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness and economic impact of screening for colorectal cancer by mass fecal occult blood testing.
    Helm JF; Russo MW; Biddle AK; Simpson KN; Ransohoff DF; Sandler RS
    Am J Gastroenterol; 2000 Nov; 95(11):3250-8. PubMed ID: 11095350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for colorectal cancer.
    Mandel JS
    Curr Opin Gen Surg; 1994; ():79-84. PubMed ID: 7584018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for colorectal cancer screening.
    Bretthauer M
    Best Pract Res Clin Gastroenterol; 2010 Aug; 24(4):417-25. PubMed ID: 20833346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.